Action Point Financial Planning’s NewAmsterdam Pharma NAMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-13
Closed -$441 – 1768
2026
Q2
$441 Buy
+13
New +$428 ﹤0.01% 2646

Other funds holding NAMS

Action Point Financial Planning's NAMS Position: Q3 2026 in Review

Action Point Financial Planning sold out of NewAmsterdam Pharma (NAMS) in Q3 2026, closing a stake of 13 shares — an estimated $441 sold.

Action Point Financial Planning first reported a position in NAMS in Q2 2026 and held it in 1 quarter. The position peaked at $441 in Q2 2026. 183 funds tracked by Wall St. Rank hold NAMS as of Q3 2026.

  • Action Point Financial Planning reported no remaining NewAmsterdam Pharma position as of Q3 2026 after selling out during the quarter.
  • Action Point Financial Planning sold 13 NewAmsterdam Pharma shares in Q3 2026, an estimated $441.
  • Action Point Financial Planning first reported a position in NewAmsterdam Pharma in Q2 2026 and held it in 1 quarter.
  • Action Point Financial Planning's NewAmsterdam Pharma position peaked at $441 in Q2 2026.
  • 183 funds tracked by Wall St. Rank held NewAmsterdam Pharma as of Q3 2026.

Based on Action Point Financial Planning's 13F filing for Q3 2026, filed 13 Nov 2026.